These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16002657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gene-based vaccines: Recent developments.
    Liu MA.
    Curr Opin Mol Ther; 2010 Feb; 12(1):86-93. PubMed ID: 20140820
    [Abstract] [Full Text] [Related]

  • 4. Human clinical trials of plasmid DNA vaccines.
    Liu MA, Ulmer JB.
    Adv Genet; 2005 Feb; 55():25-40. PubMed ID: 16291211
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control.
    Kumar A, Samant M.
    Parasite Immunol; 2016 May; 38(5):273-81. PubMed ID: 27009772
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DNA vaccines: a review.
    Liu MA.
    J Intern Med; 2003 Apr; 253(4):402-10. PubMed ID: 12653868
    [Abstract] [Full Text] [Related]

  • 8. The evolution of DNA vaccines.
    Apostolopoulos V, Plebanski M.
    Curr Opin Mol Ther; 2000 Aug; 2(4):441-7. PubMed ID: 11249775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bacterial toxin's DNA vaccine serves as a strategy for the treatment of cancer, infectious and autoimmune diseases.
    Behzadi E, Halabian R, Hosseini HM, Fooladi AAI.
    Microb Pathog; 2016 Nov; 100():184-194. PubMed ID: 27671283
    [Abstract] [Full Text] [Related]

  • 12. DNA vaccines: technology and application as anti-parasite and anti-microbial agents.
    Alarcon JB, Waine GW, McManus DP.
    Adv Parasitol; 1999 Nov; 42():343-410. PubMed ID: 10050276
    [Abstract] [Full Text] [Related]

  • 13. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases.
    Fuller DH, Loudon P, Schmaljohn C.
    Methods; 2006 Sep; 40(1):86-97. PubMed ID: 16997717
    [Abstract] [Full Text] [Related]

  • 14. The processing of antigens delivered as DNA vaccines.
    Howarth M, Elliott T.
    Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
    [Abstract] [Full Text] [Related]

  • 15. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM.
    J Cell Biochem Suppl; 1998 Jun; 30-31():304-11. PubMed ID: 9893284
    [Abstract] [Full Text] [Related]

  • 16. Modulating the immune response to genetic immunization.
    Cohen AD, Boyer JD, Weiner DB.
    FASEB J; 1998 Dec; 12(15):1611-26. PubMed ID: 9837851
    [Abstract] [Full Text] [Related]

  • 17. [DNA vaccines].
    Smahel M.
    Cas Lek Cesk; 2002 Sep 22; 141 Suppl():26-32. PubMed ID: 12428419
    [Abstract] [Full Text] [Related]

  • 18. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL, Doolan DL.
    Dev Biol (Basel); 2000 Sep 22; 104():121-32. PubMed ID: 11713810
    [Abstract] [Full Text] [Related]

  • 19. Current progress of DNA vaccine studies in humans.
    Lu S, Wang S, Grimes-Serrano JM.
    Expert Rev Vaccines; 2008 Mar 22; 7(2):175-91. PubMed ID: 18324888
    [Abstract] [Full Text] [Related]

  • 20. Development of dengue DNA vaccines.
    Danko JR, Beckett CG, Porter KR.
    Vaccine; 2011 Sep 23; 29(42):7261-6. PubMed ID: 21777640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.